Method for determining content of ephedra in ephedra-monkshood-liquorice compound preparation

By using high-performance liquid chromatography combined with ultrasonic extraction and distillation in Mafugan compound preparation, the problem of low ephedra content detection is solved, and more accurate ephedra content determination is achieved, improving the accuracy of the test results and the drug product Quality control.

CN118980753APending Publication Date: 2024-11-19SHANDONG TIANSHUN PHARMA
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410843004.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-27
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The existing Mafugan compound preparations have incomplete extraction, resulting in low measured content, and a more accurate detection method is needed.

Method used

The test sample solution was prepared by high-performance liquid chromatography by combining ultrasonic extraction and distillation. Polar ether-linked phenyl bonded silica gel was used as the filler, methanol-0.092% phosphoric acid solution was the mobile phase, and the detection wavelength was 205- 215 nm, flow rate 0.8-1.2 ml/min, column temperature 25℃-35℃, ephedrine hydrochloride and pseudoephedrine hydrochloride were measured.

Benefits of technology

The degree of extraction of the active ingredients of ephedra was significantly improved, and the measured ephedra content was greater than 8.5mg/g, which improved the accuracy of the detection results. The specificity, system applicability, linearity, precision, accuracy and durability of the method are all Good, able to effectively control the quality of the drug.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118980753A_ABST
    Figure CN118980753A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of medicine detection, and particularly relates to a method for determining the content of ephedra in an ephedra-monkshood-liquorice compound preparation. The method adopts a high performance liquid chromatography, and the chromatographic conditions are as follows: polar ether connected phenyl bonded silica gel is used as a filler; a methanol-0. 092% phosphoric acid solution is used as a mobile phase, and the volume ratio of methanol to the 0.092% phosphoric acid solution is 1.5: 98.5; the detection wavelength is 205 to 215 nm; the flow velocity is 0.8-1.2 ml / min; the column temperature is 25-35 DEG C; compared with a method for preparing the sample solution only by adopting a distillation method, the method disclosed by the invention has the advantages that the extraction degree of effective components of ephedra in the ephedra-monkshood-liquorice compound preparation can be remarkably improved, and the accuracy of a detection result is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug detection, and particularly relates to a method for determining the content of ephedra in a Mafugan compound preparation. Background Art

[0002] Mafugan compound preparation is a Chinese medicine compound preparation made of Chinese medicine honey ephedra, aconite, and roasted licorice as raw materials. The drug has currently obtained clinical approval and is undergoing clinical experimental research. Patent Publication No. CN105560420A discloses a pharmaceutical composition for treating cough after infection, which is composed of 6-20 parts of aconite, 3-12 parts of honey ephedra, and 3-12 parts of licorice. It has the functions of warming the kidney and promoting yang, promoting lung and relieving cough; it has good antitussive, antiasthmatic and anti-inflammatory effects. After long-term observation, it is used to treat cough after cold, "no need to distinguish between the exterior and interior, deficiency and excess, cold and heat", and can be used when cough after infection is seen. It can quickly remove cough symptoms, treat both the symptoms and the root cause, and the patient's physical condition is significantly improved after healing, and it is not easy to catch a cold, and the cough after cold does not recur. The patent discloses the prescription of Mafugan compound preparation, but the detection method of the effective ingredient is not disclosed.

[0003] Patent Publication No. CN104849369A A method for testing the quality of Mafugan drugs, discloses a method for determining the content of ephedra in Mafugan compound preparations, and a high performance liquid chromatography method for determining the content of ephedra, which specifically discloses: the chromatographic conditions and system suitability test use polar ether-connected phenyl bonded silica gel as a filler; methanol-0.092% phosphoric acid solution (1.5:98.5) as the mobile phase, wherein the phosphoric acid solution contains 0.04% triethylamine and 0.02% di-n-butylamine; the detection wavelength is 210nm. The number of theoretical plates calculated based on the ephedrine hydrochloride peak should not be less than 3000. Preparation of reference solution: Take appropriate amounts of ephedrine hydrochloride reference substance and pseudoephedrine hydrochloride reference substance, accurately weigh them, and add the mobile phase to make a mixed solution containing 30μg and 15μg per 1ml. Preparation of test solution: take test sample, weigh 0.5g, put in distillation bottle, add sodium chloride 7.5g, add distilled water 30ml, add 20% sodium hydroxide solution 100ml, mix, distill, collect distillate nearly 95ml with 100ml measuring bottle containing 0.5mol / L hydrochloric acid solution 4ml in advance, add water to scale, shake up, filter, take subsequent filtrate, and obtain test solution. Accurately draw reference solution and test solution 10μl respectively, inject liquid chromatograph, measure, and obtain. The effective ingredient content of licorice determined by the method is about 1.2mg / g test sample, and the inventor finds in practice that the content is relative to the actual honey ephedra feeding amount, and the content result measured is low, therefore, it is necessary to improve the detection method, and find a method that can more accurately measure the ephedra content in the compound preparation. Summary of the invention

[0004] The present invention aims to provide a method for determining the content of ephedra in Mafugan compound preparation. The content of the effective component of ephedra measured by the content determination method is higher and the result is more accurate.

[0005] The present invention is achieved by adopting the following technical solutions:

[0006] A method for determining the content of ephedra in a Mafugan compound preparation, the method adopts high performance liquid chromatography, and the chromatographic conditions are: polar ether connected phenyl bonded silica gel as a filler; methanol-0.092% phosphoric acid solution as a mobile phase, the volume ratio of methanol to 0.092% phosphoric acid solution is 1.5:98.5; the detection wavelength is 205-215nm; the flow rate is 0.8-1.2ml / min; the column temperature is 25℃-35℃;

[0007] Preparation of reference solution: Take appropriate amount of ephedrine hydrochloride reference substance and pseudoephedrine hydrochloride reference substance, weigh accurately, add methanol to prepare mixed solutions containing 40μg of each per 1ml, and obtain;

[0008] Preparation of the sample solution: Take 2.0g of the sample, accurately weigh it, put it in a stoppered conical flask, accurately add 100mL of 1.44% phosphoric acid, weigh it, ultrasonicate it for 10-30min, let it cool, make up the reduced weight with 1.44% phosphoric acid, shake it well, filter it, accurately measure 50mL of the filtrate and put it in a round-bottom flask, add 120mL of 5mol / L sodium hydroxide, shake it well, add 7.5g of sodium chloride, add 50mL of water, distill it, collect about 150mL of the distillate in a 200mL volumetric flask pre-filled with 10mL of 0.5mol / L hydrochloric acid solution, add water to the scale, shake it well, filter it, and take the filtrate to obtain;

[0009] Injection volume: 10 μl.

[0010] Determination method: Accurately pipette 10μl of reference solution and test solution respectively, inject into liquid chromatograph, and determine.

[0011] In the above content determination method, the Mafugan compound preparation is made of the following raw materials in parts by weight: 6-20 parts of aconite root, 3-12 parts of honey ephedra, and 3-12 parts of roasted licorice.

[0012] Preferably, in the above-mentioned content determination method, the Mafugan compound preparation is made of the following raw materials in parts by weight: 9 parts of aconite root, 6 parts of honey ephedra, and 6 parts of roasted licorice.

[0013] In the above content determination method, the 0.092% phosphoric acid solution contains 0.04% triethylamine and 0.02% di-n-butylamine.

[0014] In the above-mentioned content determination method, the ultrasonic treatment time is 20 minutes.

[0015] In the above content determination method, the detection wavelength is 210 nm.

[0016] In the above content determination method, the flow rate is 1.0 ml / min.

[0017] In the above content determination method, the column temperature is 30°C

[0018] In the above-mentioned content determination method, the ultrasonic treatment conditions are power 250W and frequency 40kHz.

[0019] In the present invention, the concentrations of the 0.092% phosphoric acid solution and 1.44% phosphoric acid are mass / volume percentage concentrations; for example, 1.44% phosphoric acid contains 1.44g of phosphoric acid in 100ml of water.

[0020] The main active ingredients of ephedra are ephedrine hydrochloride and pseudoephedrine hydrochloride. When determining the content of ephedra, ephedrine hydrochloride (C 10 H 15 NO·HCl) and pseudoephedrine hydrochloride (C 10 H 15 The total amount of NO·HCl).

[0021] Honey ephedra is a processed product of ephedra, which is recorded in the Chinese Pharmacopoeia 2020 edition, Part I. In the Ma Fu Gan compound preparation of the present application, honey ephedra is used as the ephedra medicine.

[0022] The present invention has the following beneficial effects:

[0023] (1) In the preparation method of the test solution in CN104849369A, the effective ingredients of ephedra in the test sample are extracted by distillation, and the extraction is incomplete. The effective ingredient content of ephedra in the measured sample is low, averaging about 1.2 mg / g. The method for determining the content of ephedra in the Mafugan compound preparation of the present invention improves the extraction method of the test solution. The test solution is prepared by first ultrasonic extraction and then distillation extraction, which can significantly improve the extraction degree of the effective ingredients of ephedra in the Mafugan compound preparation. The average effective ingredient content of ephedra in the sample measured by the method for determining the content of ephedra in the Mafugan compound preparation of the present invention is greater than 8.5 mg / g, thereby improving the accuracy of the test result.

[0024] (2) The invented method for determining the content of ephedra in the Mafugan compound preparation was used to measure the content of honey ephedra in Kemin capsules based on the total amount of ephedrine hydrochloride and pseudoephedrine hydrochloride. The specificity, system applicability, linearity, precision, accuracy and durability were all good, indicating that the established method can effectively control the quality of this product. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1It is a comparison chart of specificity experiment results. In the figure, data 1 is the reference solution chart, data 2 is the test solution chart of Kemin Capsules, data 3 is the negative preparation chart without honey ephedra, and data 4 is the blank solvent chart.

[0026] Figure 2 This is the linear relationship between ephedrine hydrochloride concentration and peak area.

[0027] Figure 3 This is the linear relationship between pseudoephedrine hydrochloride concentration and peak area. DETAILED DESCRIPTION

[0028] The present application will be further described below in conjunction with the accompanying drawings and specific implementation methods so that those skilled in the art can better understand the present application, but the present invention is not limited thereto.

[0029] Unless otherwise specified, the experimental materials and reagents used in the examples of the present invention are all consumables and reagents that can be obtained from conventional commercial channels.

[0030] The samples of the Mafugan compound preparation (Kemin) used in the embodiments of the present invention are prepared with reference to the prescription and preparation method in the preclinical research materials reported to the State Food and Drug Administration. The preparation has been approved for clinical research and is currently undergoing clinical research. The declared preparation is a capsule, and the Mafugan compound preparation is referred to as Kemin capsule hereinafter.

[0031] The Mafugan compound preparation (kemin) sample and negative control sample used in the examples of the present invention were provided by Jinan Kangzhong Pharmaceutical Technology Development Co., Ltd. The preparation method thereof is the same as that of the sample of patent publication number CN104849369A.

[0032] Example 1 Study on sample extraction method

[0033] With reference to the chromatographic conditions in the ephedra determination method disclosed in Patent Publication No. CN104849369A, the extraction method of the test sample was improved and studied.

[0034] 1.1 Extraction method screening

[0035] Take about 2.0g of Kemin Capsules 230201 batch, accurately weigh, place in a stoppered conical flask, accurately add 1.44% phosphoric acid 100mL, weigh, heat reflux extraction for 20min, follow the above test sample preparation method, starting from "cooling, using 1.44% phosphoric acid to make up the reduced weight", and measure the ephedrine hydrochloride and pseudoephedrine hydrochloride contents. The results are as follows:

[0036] Table 1 Test solution preparation method extraction method screening results

[0037] sample Ephedrine hydrochloride (mg / g) Pseudoephedrine hydrochloride (mg / g) Total amount (mg / g) Ultrasound 20min 6.29 2.34 8.65 Heat to reflux for 20 min 5.56 2.06 7.62

[0038] The results of extraction method screening showed that the content of target components obtained by ultrasonic extraction was higher than that by reflux extraction, so the extraction method in the preparation method of the test solution was set as ultrasonic extraction.

[0039] 1.2 Ultrasound time screening

[0040] Take about 2.0g of Kemin Capsules 230201 batch, accurately weigh, place in a stoppered conical flask, accurately add 1.44% phosphoric acid 100mL, weigh, and treat with ultrasound (power 250W, frequency 40kHz) for 20min, 30min, and 40min respectively. According to the above test sample preparation method, from "cooling, using 1.44% phosphoric acid to make up the reduced weight", the same operation is carried out, and the ephedrine hydrochloride and pseudoephedrine hydrochloride contents are determined. The results are as follows:

[0041] Table 2 Test solution preparation method Ultrasonic time screening results

[0042]

[0043] The results showed that the RSDs of ephedrine hydrochloride, pseudoephedrine hydrochloride, ephedrine and the total amount at different ultrasonic times were 1.8%, 1.7% and 1.7%, respectively, all less than 3.0%. The ultrasonic time in the preparation method of the test solution was set at 20 minutes.

[0044] First, the content of honey ephedra in Kemin capsule (measured in ephedrine hydrochloride (C 10 H 15 NO·HCl) and pseudoephedrine hydrochloride (C 10 H 15 The total amount of NO·HCl) is tentatively determined as follows:

[0045] Chromatographic conditions and system suitability test: polar ether-connected phenyl-bonded silica gel was used as filler; methanol-0.092% phosphoric acid solution (containing 0.04% triethylamine and 0.02% di-n-butylamine) (1.5:98.5) was used as mobile phase; detection wavelength was 210nm. Flow rate was 1.0ml / min; column temperature was 30℃;

[0046] Preparation of reference solution: Take appropriate amounts of ephedrine hydrochloride reference substance and pseudoephedrine hydrochloride reference substance, weigh them accurately, and add methanol to prepare mixed solutions containing 40 μg of each per 1 ml.

[0047] Preparation of the sample solution: Take about 2.0 g of Kemin capsules, accurately weigh them, put them in a stoppered conical flask, accurately add 100 mL of 1.44% phosphoric acid, weigh the weight, ultrasonically treat (power 250 W, frequency 40 kHz) for 20 min, let cool, make up the reduced weight with 1.44% phosphoric acid, shake well, filter, accurately measure 50 mL of the filtrate and put it in a round-bottom flask, add 120 mL of 5 mol / L sodium hydroxide, shake well, add 7.5 g of sodium chloride, add 50 mL of water, distill, use a 200 mL volumetric flask pre-filled with 10 mL of 0.5 mol / L hydrochloric acid solution, collect about 150 mL of the distillate, add water to the scale, shake well, filter, and take the filtrate.

[0048] Determination method: Accurately pipette 10μl of reference solution and test solution respectively, inject into liquid chromatograph, and determine.

[0049] Example 2 Methodological verification experiment of the content determination method of ephedra of the present invention

[0050] 2.1 Specificity and system suitability

[0051] Test solution: Take the negative preparation of Kemin Capsules batch 230201, which does not contain honey ephedra, and prepare the test solution according to the above method.

[0052] Blank solvent: Take an appropriate amount of water.

[0053] Reference substance solution: Take appropriate amounts of ephedrine hydrochloride reference substance and pseudoephedrine hydrochloride reference substance, weigh them accurately, and add methanol to prepare mixed solutions containing 41.90 μg of ephedrine hydrochloride reference substance and 41.96 μg of pseudoephedrine hydrochloride reference substance per 1 ml.

[0054] The determination method is set according to the above chromatographic conditions. 10 μl of each of the above solutions is accurately drawn and injected into the liquid chromatograph for determination and recording of the chromatogram. The specificity test results are as follows:

[0055] Table 3 Negative interference results

[0056] Sample name Ephedrine hydrochloride peak area Pseudoephedrine hydrochloride peak area Test product 714395 282299 Negative test article 1550 2638 Negative interference peak area / test sample peak area 0.2% 0.9%

[0057] Table 4 System suitability test results 1

[0058] name Theoretical plates Separation Ephedrine hydrochloride >3000 >1.5 Pseudoephedrine Hydrochloride >3000 >1.5

[0059] Table 5 System suitability test results 2

[0060] Reference substance name 1 2 3 4 5 Average peak area RSD% Ephedrine hydrochloride 955136 961069 975033 945532 952358 957826 1.16 Pseudoephedrine Hydrochloride 962483 965585 981308 952924 962023 964865 1.07

[0061] See the specificity comparison chart for Figure 1The specificity results showed that the test solution had corresponding chromatographic peaks within the retention time of each chromatographic peak of the reference solution; the blank solvent had no chromatographic peak within the corresponding retention time; trace peaks were detected in the negative preparation, but the proportion was less than 1%, with limited interference and little effect on the content determination results.

[0062] The results of the system suitability experiment showed that the target peaks of the test solution were well separated, and the number of theoretical plates and tailing factors were within a reasonable range.

[0063] In summary, the above method was used to determine the contents of ephedrine hydrochloride and pseudoephedrine hydrochloride in Kemin Capsules. The method has strong specificity and good system applicability.

[0064] 2.2 Linearity

[0065] Take the stock solutions of ephedrine hydrochloride reference substance and pseudoephedrine hydrochloride reference substance respectively, dilute them with methanol to prepare linear solutions of different concentrations, accurately pipette 10 μl of each linear solution, inject it into the liquid chromatograph, measure, and record the chromatogram.

[0066] With the concentration of the reference substance as the horizontal axis and the peak area as the vertical axis, a standard curve was drawn and the regression equation was calculated.

[0067] Acceptable criteria: The regression equation correlation coefficient is greater than 0.995.

[0068] Table 6 Ephedrine hydrochloride linearity test results

[0069] Serial number Linear 1 Linear 2 Linear 3 Linear 4 Linear 5 Linear 6 Concentration (μg / ml) 4.0120 20.0600 32.0960 40.1200 60.1800 80.2400 Peak area 102115 453645 721646 908407 1370944 1813115

[0070] With concentration as the X-axis and peak area as the Y-axis, a linear regression equation is drawn as follows:

[0071] The regression equation is: y = 22555x + 5150.8, r = 0.9999. The results show that the injection amount of ephedrine hydrochloride is in the range of 0.04-0.80 μg, and has a good linear relationship with the peak area (r ≥ 0.995).

[0072] Table 7 Pseudoephedrine hydrochloride linearity test results

[0073] Serial number Linear 1 Linear 2 Linear 3 Linear 4 Linear 5 Linear 6 Concentration (μg / ml) 4.2255 21.1277 33.8043 42.2553 63.3830 84.5106 Peak area 99308 477062 762506 964128 1459193 1936335

[0074] With concentration as the X-axis and peak area as the Y-axis, a linear regression equation is drawn as follows:

[0075] The regression equation is: y = 22982x-5173, r = 0.9999. The results show that the method for the determination of pseudoephedrine hydrochloride has a good linear relationship with the peak area in the range of 0.04-0.85 μg (r ≥ 0.995).

[0076] 2.3 Precision test

[0077] 2.3.1 Repeatability test

[0078] Take Kemin Capsules and conduct experiments according to the tentative test solution preparation method, chromatographic conditions and determination method in Example 1 to prepare 6 test samples, measure and calculate the content.

[0079] Acceptable standard: If the relative standard deviation of the content results of 6 test samples is less than 3.0%, the method is considered to have good repeatability.

[0080] Table 8 Repeatability test results of person A, date A, instrument A

[0081] project 1 2 3 4 5 6 average RSD% Ephedrine hydrochloride (mg / g) 6.38 6.28 6.10 6.34 6.24 6.06 6.23 2.1 Pseudoephedrine hydrochloride (mg / g) 2.40 2.39 2.30 2.38 2.37 2.27 2.35 2.3 Total content (mg / g) 8.78 8.66 8.39 8.72 8.61 8.34 8.58 2.1

[0082] This method was used to determine the total content of ephedrine hydrochloride and pseudoephedrine hydrochloride, and the repeatability RSD was 2.1% (RSD≤3.0%), indicating that the determination method had good repeatability.

[0083] 2.3.2 Intermediate precision test

[0084] Take batch 230201 of Kemin Capsules, and personnel B prepared 6 test solutions according to the above test solution preparation method on date B, and measured them with instrument B. The results are as follows:

[0085] Table 9 Test results of person B, date B, instrument B

[0086] project 1 2 3 4 5 6 average RSD% Ephedrine hydrochloride (mg / g) 5.91 5.96 5.91 5.97 5.91 5.92 5.93 0.5 Pseudoephedrine hydrochloride (mg / g) 2.24 2.23 2.23 2.26 2.22 2.24 2.24 0.7 Total content (mg / g) 8.15 8.19 8.14 8.23 8.12 8.18 8.17 0.5

[0087] Take the test results of date A, person A, and instrument A, and compare them with the test results of date B, person B, and instrument B as the intermediate precision test data. The comparison results are as follows:

[0088] Table 10 Intermediate precision test results

[0089]

[0090] The intermediate precision RSD of ephedrine hydrochloride and pseudoephedrine hydrochloride determined by this method was 3.0% (≤3.0%), indicating that the intermediate precision of this method was good.

[0091] 2.3.3 Solution stability test

[0092] Take the test solution, and at room temperature for 0, 2, 7, 10, and 18 hours, accurately pipette the test solution, inject it into the liquid chromatograph, and measure it. Calculate the RSD of the peak area of ​​the test solution.

[0093] Acceptable standard: The RSD of the chromatographic peak areas of ephedrine hydrochloride and pseudoephedrine hydrochloride should be less than 2.0%, indicating that the solution has good stability.

[0094] Table 11 Solution stability test peak area results

[0095] project 0:00 2 o'clock 7 o'clock 10 o'clock 18:00 average RSD% Ephedrine hydrochloride 727052 742293 728368 733786 729214 732142.6 0.8 Pseudoephedrine Hydrochloride 270011 281765 272983 278732 278179 276334 1.7

[0096] The above results show that the peak areas of the chromatographic peaks of ephedrine hydrochloride and pseudoephedrine hydrochloride in the test solution have good solution stability within 18 hours (RSD≤2.0%).

[0097] 2.4 Accuracy

[0098] Take batch 230201 of Kemin Capsules and conduct the experiment according to the chromatographic conditions and determination method under the preparation method of the test solution. The preparation method of the test solution is as follows:

[0099] Take about 1.0g of Kemin Capsule 230201 batch, accurately weigh it, put it in a stoppered conical bottle, add about the amount of ephedrine hydrochloride reference substance and pseudoephedrine hydrochloride reference substance (reference substance powder) contained in 1.0g honey ephedra, accurately add 100mL of 1.44% phosphoric acid, weigh it, ultrasonically treat it (power 250W, frequency 40kHz) for 20min, let it cool, make up the reduced weight with 1.44% phosphoric acid, shake it well, filter it, accurately measure 50mL of the filtrate, put it in a round-bottom flask, add 120mL of 5mol / L sodium hydroxide, shake it well, add 7.5g of sodium chloride, add 50mL of water, distill it, collect about 150mL of distillate with a 200mL volumetric flask pre-filled with 10mL of 0.5mol / L hydrochloric acid solution, add water to the scale, shake it well, filter it, and take the filtrate to get it. Prepare 6 portions in the same way.

[0100] Accurately pipette 10 μl of the test solution and reference solution, respectively, and inject them into the liquid chromatograph for determination and calculation of the recovery rate. The results are as follows:

[0101]

[0102] Table 12 Ephedrine hydrochloride recovery results

[0103]

[0104] Table 13 Pseudoephedrine Hydrochloride Recovery Results

[0105] Sample No. Sampling volume (g) Measured results (mg) Test sample content (mg) Amount of reference substance added (mg) Recovery rate (%) 1 1.0071 5.79 2.37 3.56 96.1 2 1.0031 3.70 2.36 1.4 92.4 3 1.0075 5.80 2.37 3.52 97.4 4 1.0043 4.06 2.36 1.73 98.3 5 1.0038 4.55 2.36 2.3 95.2 6 1.0065 3.71 2.37 1.43 93.7 average / / / / 95.5 RSD% / / / / 2.3

[0106] The test results show that the recovery rate of ephedrine hydrochloride ranges from 91.8% to 97.2%, and the RSD of the 6 recovery rate results is 2.0%; the recovery rate of pseudoephedrine hydrochloride ranges from 92.4% to 98.3%, and the RSD of the 6 recovery rate results is 2.3%. The recovery rates are all between 90% and 108%, and the RSD is less than 3%, indicating that this method has good accuracy.

[0107] 2.5 Durability test

[0108] 2.5.1 Wavelength

[0109] Batch 230201 of Kemin Capsules was tested according to the above method, with the wavelength in the chromatographic conditions changed, and the durability test was carried out. The results are as follows:

[0110] Table 14 Test results of ephedrine hydrochloride and pseudoephedrine hydrochloride at different wavelengths

[0111] Wavelength (nm) 205 210 215 average RSD% Total content (mg / g) 8.53 8.58 8.51 8.54 0.4

[0112] The RSD of the total content of ephedrine hydrochloride and pseudoephedrine hydrochloride is 0.4% (≤3.0%), indicating that the durability is good within the wavelength range of 205-215nm.

[0113] 2.5.2 Flow rate

[0114] Batch 230201 of Kemin Capsules was tested according to the above method, with the flow rate in the chromatographic conditions changed, and the durability test was carried out. The results are as follows:

[0115] Table 15 Test results of ephedrine hydrochloride and pseudoephedrine hydrochloride at different flow rates

[0116] Flow rate (ml / min) 0.8 1.0 1.2 average RSD% Total content (mg / g) 8.69 8.58 8.61 8.63 0.7

[0117] The RSD of the total content of ephedrine hydrochloride and pseudoephedrine hydrochloride was 0.7% (≤3.0%), indicating that the durability was good within the flow rate range of 0.8-1.2 ml / min.

[0118] 2.5.3 Chromatographic columns

[0119] Take the 230201 batch of Kemin Capsules and test them according to the above method. Use different polar ethers to connect the phenyl bonded silica gel column for determination. The results are as follows:

[0120] Table 16 Test results of ephedrine hydrochloride and pseudoephedrine hydrochloride under different chromatographic columns

[0121]

[0122] When the method uses different chromatographic columns to measure the total content of ephedrine hydrochloride and pseudoephedrine hydrochloride, the deviation of the measurement results is less than 3% (8.58 / 8.64*100=99.3%), and there is no significant difference in the measurement results (8.58 / 8.64=0.993), indicating good durability.

[0123] 2.5.4 Mobile phase ratio

[0124] Take the 230201 batch of Kemin Capsules and test them according to the above method. Change the proportion of mobile phase in the chromatographic conditions and conduct durability test. The results are as follows:

[0125] Table 17 Test results of ephedrine hydrochloride and pseudoephedrine hydrochloride at different mobile phase ratios

[0126]

[0127] The RSD of the total content of ephedrine hydrochloride and pseudoephedrine hydrochloride was 2.6% (≤3.0%), indicating that the durability was good when the ratio of the mobile phase methanol:0.092% phosphoric acid (containing 0.04% triethylamine and 0.02% di-n-butylamine) was in the range of 1.0:99.0-2.0:98.0.

[0128] 2.5.5 Column temperature

[0129] Take batch 230201 of Kemin Capsules and test them according to the above method. Change the column temperature in the chromatographic conditions and conduct durability test. The results are as follows:

[0130] Table 18 Test results of ephedrine hydrochloride and pseudoephedrine hydrochloride at different column temperatures

[0131] Column temperature (℃) 25 30 35 average RSD% Total content (mg / g) 8.98 8.58 9.01 8.86 2.7

[0132] The RSD of the total content of ephedrine hydrochloride and pseudoephedrine hydrochloride was 2.7% (≤3.0%), indicating that the column had good durability when the temperature was within the range of 25°C-35°C.

[0133] 3 Summary of Methodological Validation

[0134] The results of the methodological validation of this product are summarized as follows:

[0135] Table 19 Methodological study results

[0136]

[0137]

[0138]

[0139] In summary: The content of honey ephedra in Kemin capsules was calculated by the total amount of ephedrine hydrochloride and pseudoephedrine hydrochloride using the established method, and the specificity, system applicability, linearity, precision, accuracy and durability were all good, indicating that the established method can effectively control the quality of this product.

Claims

1. A method for determining the content of ephedra in a Mafugan compound preparation, characterized in that: The method adopts high performance liquid chromatography, and the chromatographic conditions are: polar ether-connected phenyl-bonded silica gel is used as a filler; The mobile phase is methanol-0.092% phosphoric acid solution, the volume ratio of methanol to 0.092% phosphoric acid solution is 1.5:98.5; the detection wavelength is 205-215nm; the flow rate is 0.8-1.2ml / min; the column temperature is 25℃-35℃; Preparation of reference solution: Take appropriate amount of ephedrine hydrochloride reference substance and pseudoephedrine hydrochloride reference substance, weigh accurately, add methanol to make mixed solutions containing 40μg of each per 1ml, and obtain; Preparation of the sample solution: Take 2.0g of the sample, accurately weigh it, put it in a stoppered conical flask, accurately add 100mL of 1.44% phosphoric acid, weigh it, ultrasonicate it for 10-30min, let it cool, make up the reduced weight with 1.44% phosphoric acid, shake it well, filter it, accurately measure 50mL of the filtrate and put it in a round-bottom flask, add 120mL of 5mol / L sodium hydroxide, shake it well, add 7.5g of sodium chloride, add 50mL of water, distill it, collect about 150mL of the distillate in a 200mL volumetric flask pre-filled with 10mL of 0.5mol / L hydrochloric acid solution, add water to the scale, shake it well, filter it, and take the filtrate to obtain; Injection volume: 10 μl.

2. The content determination method according to claim 1, characterized in that: The Mafugan compound preparation is prepared from the following raw materials in parts by weight: 6-20 parts of aconite root, 3-12 parts of honey ephedra, and 3-12 parts of roasted licorice root.

3. The content determination method according to claim 2, characterized in that: The Mafugan compound preparation is prepared from the following raw materials in parts by weight: 9 parts of aconite root, 6 parts of honeyed ephedra, and 6 parts of roasted licorice.

4. The content determination method according to claim 1, characterized in that: The 0.092% phosphoric acid solution contains 0.04% triethylamine and 0.02% di-n-butylamine.

5. The content determination method according to claim 1, characterized in that: The ultrasonic treatment time is 20 min.

6. The content determination method according to claim 1, characterized in that: The detection wavelength is 210 nm.

7. The content determination method according to claim 1, characterized in that: The flow rate is 1.0 ml / min.

8. The content determination method according to claim 1, characterized in that: The column temperature was 30°C.

9. The content determination method according to claim 1, characterized in that: The ultrasonic treatment conditions are as follows: power 250 W, frequency 40 kHz.

Citation Information

Patent Citations

  • Quality detection method of ephedra sinica-aconitum napellus-liquorice medicine

    CN104849369A

  • Pharmaceutical composition for treating cough caused by infection

    CN105560420A